Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens.
about
Genome plasticity of BCG and impact on vaccine efficacyOral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against TuberculosisPrevalence of nontuberculous mycobacteria isolated from environmental samples in Iran: A meta-analysisThe TB pandemic: an old problem seeking new solutions.Recombinant Mycobacterium bovis BCG as an HIV vaccine vector.Bovine tuberculosis in African buffaloes: observations regarding Mycobacterium bovis shedding into water and exposure to environmental mycobacteriaNovel genome polymorphisms in BCG vaccine strains and impact on efficacy.Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.Immunogenicity of a protective whole cell mycobacterial vaccine in HIV-infected adults: a phase III study in TanzaniaMycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.Immunological consequences of intragenus conservation of Mycobacterium tuberculosis T-cell epitopesUnique gene expression profiles in infants vaccinated with different strains of Mycobacterium bovis bacille Calmette-Guerin.Impairments of Antigen-Presenting Cells in Pulmonary TuberculosisRhesus immune responses to SIV Gag expressed by recombinant BCG vectors are independent from pre-existing mycobacterial immunity.The success and failure of BCG - implications for a novel tuberculosis vaccine.Tuberculosis: from genome to vaccine.Molecular findings and approaches spotlighting Mycobacterium bovis persistence in cattle.Cross-reactive immunity to Mycobacterium tuberculosis DosR regulon-encoded antigens in individuals infected with environmental, nontuberculous mycobacteria.Lipidated promiscuous peptide augments the expression of MHC-II molecules on dendritic cells and activates T cells.Antituberculous vaccine development: a perspective for the endemic world.Tuberculosis: what we don't know can, and does, hurt us.From vaccine practice to vaccine science: the contribution of human immunology to the prevention of infectious disease.The role of dendritic cells in Mycobacterium tuberculosis infection.On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccinesSpatio-temporal study of environmental nontuberculous mycobacteria isolated from Wardha district in Central India.Specific Proteins in Nontuberculous Mycobacteria: New Potential Tools.Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients.Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.Live tuberculosis vaccines based onphoPmutants: a step towards clinical trialsReal vaccines in the real world: tuberculosis vaccines move south
P2860
Q24674276-B977338B-F810-42EC-8EC8-BD85811C10FDQ27313927-A3D89099-F7AE-4889-B578-D127F28D3955Q28079410-BE90FF46-33FF-40EB-900C-69285ECC5BD9Q30360726-A85A6EDE-9F6F-419E-B38F-5124CB1F10E7Q30387447-1F0A92DE-98D8-4F92-9734-998427CA9741Q33300596-263FCE6B-0077-4346-8B7C-F234109765E1Q33369563-A99B6229-B4C1-4B63-A275-1EB973854C96Q33791961-B03B43FF-6C44-4DE4-A9E9-598E0933A440Q34312118-2C435DB1-7E7C-487C-B005-F39053CC775DQ34491796-B0D26E3D-20E4-49F8-83CA-388903B6D8ECQ34985591-A1CC492D-C91C-4AC4-B61F-E74993D1AD2FQ35913637-3512DFE6-7EFF-4AE5-8913-DBDD930B510DQ35963132-0658F908-F363-4FB1-9DF0-D8705808F045Q36145561-A29F6301-8D37-429C-BCBE-3442A4A74501Q36191944-9A1E9E66-DE39-4D27-9068-0B7821E171D7Q36238724-00EAE374-534F-4A56-A20D-D3BE306DB505Q37394401-12F96761-1EE2-4103-966D-43ED1BDB1669Q37410301-2AAC6A5B-BA3E-4183-BB9A-A69ABD25C6B8Q37592378-FFEEA8B5-6986-4B33-9CBD-DF956C928B4FQ37622900-AE612BFC-047D-4C06-8305-3B296CA358B9Q37751647-8CA0ACAE-6C47-4F9D-8D0C-297FF5D5BC79Q37837477-F306DA23-A9E1-49D6-9764-A88615AD3A52Q38060048-175AE66B-171E-4085-BE0C-4EE80A007559Q38529413-323570AD-6315-4955-83AE-BE52EAF8FDD1Q38610967-04A0E59A-13C4-4132-8FC3-BE76BC213B8DQ41142611-C2659997-675F-4DC5-A6A6-9F8C80D4F11FQ42432581-70462361-5BED-460D-999C-978BC12AAD80Q45877860-47FE1C88-5DD8-4085-A591-886035307649Q51965401-908D64E2-9C8A-4D23-9C06-FE81330EF5BDQ58834940-D6D78B20-55CB-4C17-A245-E810E9E2A4ABQ58853018-C2AD731C-9B43-4F00-985F-CF9BC5CF4F4B
P2860
Differential effects of prior exposure to environmental mycobacteria on vaccination with Mycobacterium bovis BCG or a recombinant BCG strain expressing RD1 antigens.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Differential effects of prior ...... train expressing RD1 antigens.
@ast
Differential effects of prior ...... train expressing RD1 antigens.
@en
type
label
Differential effects of prior ...... train expressing RD1 antigens.
@ast
Differential effects of prior ...... train expressing RD1 antigens.
@en
prefLabel
Differential effects of prior ...... train expressing RD1 antigens.
@ast
Differential effects of prior ...... train expressing RD1 antigens.
@en
P2093
P2860
P1476
Differential effects of prior ...... train expressing RD1 antigens.
@en
P2093
Caroline Demangel
Ida Rosenkrands
Stewart T Cole
Thierry Garnier
P2860
P304
P356
10.1128/IAI.73.4.2190-2196.2005
P407
P577
2005-04-01T00:00:00Z